MANGOCEUTICALS, INC. financial data

Symbol
MGRX on Nasdaq
Location
Dallas, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 18% % -51%
Quick Ratio 1.4% %
Debt-to-equity 7.7% % -52%
Return On Equity -115% % 16%
Return On Assets -106% % 10%
Operating Margin -4143% % -253%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13,906,570 shares 459%
Common Stock, Shares, Outstanding 13,883,103 shares 550%
Entity Public Float $5,862,777 USD -56%
Common Stock, Value, Issued $1,389 USD 552%
Weighted Average Number of Shares Outstanding, Basic 11,524,275 shares 472%
Weighted Average Number of Shares Outstanding, Diluted 11,524,275 shares 472%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $466,908 USD -38%
Cost of Revenue $67,242 USD -46%
General and Administrative Expense $3,953,237 USD -6.4%
Operating Income (Loss) $19,342,271 USD -118%
Nonoperating Income (Expense) $75,850 USD 69%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $19,822,681 USD -113%
Net Income (Loss) Attributable to Parent $19,821,779 USD -113%
Earnings Per Share, Basic -3 USD/shares 68%
Earnings Per Share, Diluted -3 USD/shares 68%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $481,281 USD 551%
Inventory, Net $13,213 USD -39%
Assets, Current $598,223 USD 475%
Property, Plant and Equipment, Net $2,049 USD -33%
Operating Lease, Right-of-Use Asset $11,211 USD -85%
Intangible Assets, Net (Excluding Goodwill) $15,920,319 USD 9%
Assets $16,531,802 USD 12%
Liabilities, Current $804,275 USD -42%
Operating Lease, Liability, Noncurrent $12,167 USD -85%
Liabilities $804,275 USD -43%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,079 USD -25%
Retained Earnings (Accumulated Deficit) $37,877,913 USD -111%
Stockholders' Equity Attributable to Parent $15,729,266 USD 17%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $15,727,527 USD 14%
Liabilities and Equity $16,531,802 USD 12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,274,781 USD -130%
Net Cash Provided by (Used in) Financing Activities $2,285,000 USD 754%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 13,883,103 shares 550%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $481,281 USD 551%
Deferred Tax Assets, Valuation Allowance $4,034,291 USD 83%
Deferred Tax Assets, Gross $4,034,291 USD 83%
Operating Lease, Liability $12,167 USD -85%
Depreciation $250 USD -96%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $19,821,653 USD -113%
Lessee, Operating Lease, Liability, to be Paid $12,289 USD -86%
Operating Lease, Liability, Current $12,167 USD -82%
Lessee, Operating Lease, Liability, to be Paid, Year One $67,589 USD -5.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $122 USD -97%
Deferred Tax Assets, Operating Loss Carryforwards $3,076,580 USD 76%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $53,283,483 USD 69%
Amortization of Intangible Assets $276,815 USD
Depreciation, Depletion and Amortization $250 USD -96%
Share-based Payment Arrangement, Expense $50,979 USD 34%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%